| Serial Number | 79396856 |
| Word Mark | CONFIDON |
| Filing Date | Monday, April 15, 2024 |
| Status | 661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED |
| Status Date | Tuesday, March 25, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Translation of Words in Mark | The wording CONFIDON has no meaning in a foreign language. |
| Goods and Services | Medical and scientific research in the field of pharmaceutical preparations; providing medical and scientific research information in the field of pharmaceutical preparations. |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, June 6, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Boehringer Ingelheim International GmbH |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | DE |
| Event Date | Event Description |
| Thursday, June 6, 2024 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Friday, June 7, 2024 | APPLICATION FILING RECEIPT MAILED |
| Friday, June 7, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, October 28, 2024 | ASSIGNED TO EXAMINER |
| Tuesday, November 5, 2024 | NON-FINAL ACTION WRITTEN |
| Wednesday, November 13, 2024 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Tuesday, March 25, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, March 25, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, March 25, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Saturday, November 30, 2024 | REFUSAL PROCESSED BY IB |
| Wednesday, November 6, 2024 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Tuesday, November 12, 2024 | REFUSAL PROCESSED BY MPU |